AptaBio Therapeutics Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-16,346	-29,378	-12,062	-10,565
Depreciation & Amortization	480.81	531.35	539.11	484.62
Asset Writedown & Restructuring Costs	475.11	-	-	-
Loss (Gain) From Sale of Investments	-0.28	583.55	244.29	2,494
Loss (Gain) on Equity Investments	2,653	625.93	4.19	-
Stock-Based Compensation	211.51	234.34	186.65	123.6
Provision & Write-off of Bad Debts	373.63	-	-	-
Other Operating Activities	455.74	12,436	-2,458	631.31
Change in Accounts Receivable	159.35	-893.71	-	-
Change in Inventory	39.54	-224.87	-	-
Change in Accounts Payable	31.84	1.87	-	-
Change in Other Net Operating Assets	-3,810	3,924	-549.77	-1.91
Operating Cash Flow	-15,276	-12,160	-14,095	-6,833
Capital Expenditures	-58.67	-240.16	-1,345	-1,041
Sale of Property, Plant & Equipment	1,400	-	-	-
Cash Acquisitions	130.49	-	-	-
Sale (Purchase) of Intangibles	-	-	-46.6	-10.36
Sale (Purchase) of Real Estate	-	-	-	-65.94
Investment in Securities	6,907	13,521	-9,006	5,332
Other Investing Activities	-2,029	-55.62	60.15	27.66
Investing Cash Flow	6,489	12,854	-12,737	1,743
Long-Term Debt Issued	-	-	38,900	-
Long-Term Debt Repaid	-661.25	-134.01	-127.85	-87.95
Net Debt Issued (Repaid)	-661.25	-134.01	38,772	-87.95
Issuance of Common Stock	-	-	-	589.2
Other Financing Activities	-17.45	-33.3	-19.2	-5.24
Financing Cash Flow	-678.7	-167.31	49,854	496.01
Foreign Exchange Rate Adjustments	3.28	-1.19	5.07	16.76
Miscellaneous Cash Flow Adjustments	0	-0	-0	0
Net Cash Flow	-9,463	525.33	23,027	-4,577
Free Cash Flow	-15,335	-12,400	-15,440	-7,874
Free Cash Flow Margin	-414.69%	-368.94%	-4767.39%	-16284.04%
Free Cash Flow Per Share	-569.45	-526.76	-692.42	-353.27
Cash Interest Paid	8.43	10.2	11.47	4.49
Cash Income Tax Paid	-152.55	76.18	48.45	-34.01
Levered Free Cash Flow	-21,959	-1,924	-13,398	-
Unlevered Free Cash Flow	-20,635	201.3	-12,659	-
Change in Working Capital	-3,579	2,807	-549.77	-1.91

Source: S&P Global Market Intelligence. Standard template. Financial Sources.